OBJECTIVES: Human papillomavirus (HPV) infection causes genital warts, penile cancer and cervical cancer. Africa has one of the highest rates of penile and cervical cancers, but there are little data on high-risk human papillomavirus (HR-HPV) prevalence in heterosexual men. Knowledge of HR-HPV prevalence, risk factors and genotype distribution among heterosexual men is important to establish risk-reduction prevention strategies. METHODS: 1578 uncircumcised men aged 15-49 years who enrolled in male circumcision trials in Rakai, Uganda, were evaluated for HR-HPV from swabs of the coronal sulcus/glans using Roche HPV Linear Array. Adjusted prevalence risk ratios (adjPRRs) were estimated using modified Poisson multivariable regression. RESULTS: HPV prevalence (either high risk or low risk) was 90.7% (382/421) among HIV-positive men and 60.9% (596/978) among HIV-negative men (PRR 1.49, 95% CI 1.40 to 1.58). HIV-positive men had a significantly higher risk of infection with three or more HR-HPV genotypes (PRR=5.76, 95% CI 4.27 to 7.79). Among HIV-positive men, high-risk sexual behaviours were not associated with increased HR-HPV prevalence. Among HIV-negative men, HR-HPV prevalence was associated with self-reported genital warts (adjPRR 1.57, 95% CI 1.07 to 2.31). Among all men (both HIV negative and HIV positive), HR-HPV prevalence was associated with more than 10 lifetime sexual partners (adjPRR 1.30, 95% CI 1.01 to 1.66), consistent condom use (adjPRR 1.31, 95% CI 1.08 to 1.60) and HIV infection (adjPRR 1.80, 95% CI 1.60 to 2.02). HR-HPV prevalence was lower among men who reported no sexual partners during the past year (adjPRR 0.47, 95% CI 0.23 to 0.94). CONCLUSION: The burden of HR-HPV infection is high among heterosexual men in sub-Saharan Africa and most pronounced among the HIV-infected individuals.
OBJECTIVES: Human papillomavirus (HPV) infection causes genital warts, penile cancer and cervical cancer. Africa has one of the highest rates of penile and cervical cancers, but there are little data on high-risk human papillomavirus (HR-HPV) prevalence in heterosexual men. Knowledge of HR-HPV prevalence, risk factors and genotype distribution among heterosexual men is important to establish risk-reduction prevention strategies. METHODS: 1578 uncircumcised men aged 15-49 years who enrolled in male circumcision trials in Rakai, Uganda, were evaluated for HR-HPV from swabs of the coronal sulcus/glans using Roche HPV Linear Array. Adjusted prevalence risk ratios (adjPRRs) were estimated using modified Poisson multivariable regression. RESULTS:HPV prevalence (either high risk or low risk) was 90.7% (382/421) among HIV-positive men and 60.9% (596/978) among HIV-negative men (PRR 1.49, 95% CI 1.40 to 1.58). HIV-positive men had a significantly higher risk of infection with three or more HR-HPV genotypes (PRR=5.76, 95% CI 4.27 to 7.79). Among HIV-positive men, high-risk sexual behaviours were not associated with increased HR-HPV prevalence. Among HIV-negative men, HR-HPV prevalence was associated with self-reported genital warts (adjPRR 1.57, 95% CI 1.07 to 2.31). Among all men (both HIV negative and HIV positive), HR-HPV prevalence was associated with more than 10 lifetime sexual partners (adjPRR 1.30, 95% CI 1.01 to 1.66), consistent condom use (adjPRR 1.31, 95% CI 1.08 to 1.60) and HIV infection (adjPRR 1.80, 95% CI 1.60 to 2.02). HR-HPV prevalence was lower among men who reported no sexual partners during the past year (adjPRR 0.47, 95% CI 0.23 to 0.94). CONCLUSION: The burden of HR-HPV infection is high among heterosexual men in sub-Saharan Africa and most pronounced among the HIV-infected individuals.
Authors: Anna R Giuliano; Joel M Palefsky; Stephen Goldstone; Edson D Moreira; Mary E Penny; Carlos Aranda; Eftyhia Vardas; Harald Moi; Heiko Jessen; Richard Hillman; Yen-Hwa Chang; Daron Ferris; Danielle Rouleau; Janine Bryan; J Brooke Marshall; Scott Vuocolo; Eliav Barr; David Radley; Richard M Haupt; Dalya Guris Journal: N Engl J Med Date: 2011-02-03 Impact factor: 91.245
Authors: Aaron A R Tobian; Godfrey Kigozi; Patti E Gravitt; Changchang Xiao; David Serwadda; Kevin P Eaton; Xiangrong Kong; Maria J Wawer; Fred Nalugoda; Thomas C Quinn; Ronald H Gray Journal: AIDS Date: 2012-07-31 Impact factor: 4.177
Authors: Danielle M Backes; Maaike C G Bleeker; Chris J L M Meijer; Michael G Hudgens; Kawango Agot; Robert C Bailey; J O Ndinya-Achola; Juma Hayombe; Cornelis J A Hogewoning; Stephen Moses; Peter J F Snijders; Jennifer S Smith Journal: Int J Cancer Date: 2011-08-02 Impact factor: 7.396
Authors: Kimberly K Repp; Carrie M Nielson; Rongwei Fu; Sean Schafer; Eduardo Lazcano-Ponce; Jorge Salmerón; Manuel Quiterio; Luisa L Villa; Anna R Giuliano Journal: J Infect Dis Date: 2012-03-06 Impact factor: 5.226
Authors: Anna R Giuliano; Ji-Hyun Lee; William Fulp; Luisa L Villa; Eduardo Lazcano; Mary R Papenfuss; Martha Abrahamsen; Jorge Salmeron; Gabriella M Anic; Dana E Rollison; Danelle Smith Journal: Lancet Date: 2011-02-28 Impact factor: 79.321
Authors: Maria J Wawer; Aaron A R Tobian; Godfrey Kigozi; Xiangrong Kong; Patti E Gravitt; David Serwadda; Fred Nalugoda; Frederick Makumbi; Victor Ssempiija; Nelson Sewankambo; Stephen Watya; Kevin P Eaton; Amy E Oliver; Michael Z Chen; Steven J Reynolds; Thomas C Quinn; Ronald H Gray Journal: Lancet Date: 2011-01-06 Impact factor: 79.321
Authors: Aaron A R Tobian; Xiangrong Kong; Patti E Gravitt; Kevin P Eaton; Godfrey Kigozi; David Serwadda; Amy E Oliver; Fred Nalugoda; Frederick Makumbi; Michael Z Chen; Maria J Wawer; Thomas C Quinn; Ronald H Gray Journal: Int J Cancer Date: 2011-04-01 Impact factor: 7.396
Authors: Anne M Johnson; Catherine H Mercer; Simon Beddows; Natasha de Silva; Sarika Desai; Rebecca Howell-Jones; Caroline Carder; Pam Sonnenberg; Kevin A Fenton; Catherine Lowndes; Kate Soldan Journal: Sex Transm Infect Date: 2012-01-17 Impact factor: 3.519
Authors: Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet Journal: J Acquir Immune Defic Syndr Date: 2013-06-01 Impact factor: 3.731
Authors: Cecily Banura; Florence M Mirembe; Jackson Orem; Anthony K Mbonye; Simon Kasasa; Edward K Mbidde Journal: Infect Agent Cancer Date: 2013-07-10 Impact factor: 2.965
Authors: Gad Murenzi; Hae-Young Kim; Athanase Munyaneza; Patrick Tuyisenge; Thierry M Zawadi; Alex M Buteera; Adebola Adedimeji; Leon Mutesa; Philip E Castle; Kathryn Anastos; Joel M Palefsky Journal: J Acquir Immune Defic Syndr Date: 2020-08-15 Impact factor: 3.771